MUMBAI, MAHARASHTRA, INDIA, June 20, 2026 — Brinton Pharmaceuticals Ltd. has appointed G Sathya as Chief Executive Officer – India Cluster & JPAC, reinforcing the company’s commitment to accelerating growth, expanding market presence, and strengthening its leadership position across India and the Japan Asia Pacific (JPAC) region.
In his new role, G Sathya will lead Brinton Pharmaceuticals’ business strategy, commercial operations, organizational development, and market expansion initiatives across key geographies. He will be responsible for driving sustainable growth, enhancing operational excellence, expanding market reach, and strengthening the company’s portfolio in an increasingly competitive healthcare landscape.
A seasoned pharmaceutical leader with more than two decades of experience across dermatology, skincare, specialty pharmaceuticals, and healthcare businesses, Sathya brings a strong track record of business transformation, market expansion, and commercial leadership across multiple international markets.
Prior to joining Brinton Pharmaceuticals Ltd., he served as Chief Executive Officer and Full-Time Director at Emcutix Biopharmaceuticals Ltd., where he led the organization’s growth strategy, commercial operations, and business expansion initiatives. Under his leadership, the company strengthened its position within the dermatology and specialty healthcare segments while building a foundation for future growth.
Before Emcutix, Sathya spent over a decade in senior leadership roles with Galderma and Nestlé Skin Health India. Most recently, he served as Managing Director – South Asia at Galderma, where he was responsible for driving business growth, strengthening market leadership, and expanding the company’s dermatology and skincare portfolio across the region.
Earlier, he held the position of Managing Director – South Asia at Nestlé Skin Health India, leading strategic initiatives that enhanced business performance and deepened market penetration across South Asia. During this period, he played a pivotal role in strengthening the organization’s commercial capabilities, customer engagement, and market presence.
His international leadership experience also includes serving as President & Country Manager at Galderma Philippines Inc., where he successfully led operations in the Philippines and drove business growth in a dynamic healthcare environment.
Prior to assuming country and regional leadership responsibilities, Sathya held key commercial roles with Galderma India, including Head Marketing and Marketing Manager, where he contributed significantly to brand development, portfolio growth, and market expansion strategies.
Throughout his career, Sathya has demonstrated expertise in pharmaceutical leadership, strategic planning, commercial excellence, business development, market access, customer engagement, and organizational transformation. His ability to build high-performing teams and deliver sustained business growth has earned him recognition as one of the industry’s accomplished healthcare leaders.
In his new position at Brinton Pharmaceuticals, Sathya is expected to play a critical role in strengthening the company’s regional footprint, accelerating innovation-led growth, expanding access to healthcare solutions, and enhancing customer value across India and the broader Asia-Pacific region.
About Brinton Pharmaceuticals Ltd.
Brinton Pharmaceuticals Ltd. is one of the fastest-growing pharmaceutical companies with a rapidly expanding global presence. The company is committed to helping people live better and live longer by delivering safe, affordable, and innovative healthcare solutions that address evolving medical needs throughout every stage of life.
With strong capabilities across research and development, manufacturing, marketing, and sales, Brinton continues to build a diverse healthcare portfolio while expanding its global footprint. Supported by a dedicated workforce and a commitment to innovation, the company focuses on improving patient outcomes and creating long-term value for healthcare professionals, partners, and communities worldwide.
Read Also : When HR “Produces Nothing”: A Response to Jennifer Sey’s Anti-HR Vision
The Fine Balance: Navigating Work, Life, and Mental Wellbeing
Mind the Leadership Gap – From Learning to Real-World Impact
How the Adecco Group is empowering its employees for the future of work
